Computer Hardware
Compare Stocks
2 / 10Stock Comparison
BGIN vs HIVE
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
BGIN vs HIVE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Computer Hardware | Information Technology Services |
| Market Cap | $357M | $715M |
| Revenue (TTM) | $302M | $115M |
| Net Income (TTM) | $66M | $21M |
| Gross Margin | 42.2% | 21.8% |
| Operating Margin | 27.0% | 1.4% |
| Forward P/E | 6.8x | — |
| Total Debt | $445K | $55M |
| Cash & Equiv. | $115M | $23M |
Quick Verdict: BGIN vs HIVE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BGIN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.95
- Rev growth 17.5%, EPS growth -52.5%, 3Y rev CAGR 141.3%
- Lower volatility, beta 1.95, Low D/E 0.2%, current ratio 3.21x
HIVE is the clearest fit if your priority is long-term compounding.
- 27.7% 10Y total return vs BGIN's -20.6%
- +65.9% vs BGIN's -20.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 17.5% revenue growth vs HIVE's 0.7% | |
| Quality / Margins | 21.8% margin vs HIVE's -2.6% | |
| Stability / Safety | Beta 1.95 vs HIVE's 3.16, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +65.9% vs BGIN's -20.6% | |
| Efficiency (ROA) | 28.5% ROA vs HIVE's 3.0%, ROIC 61.8% vs 0.3% |
BGIN vs HIVE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BGIN leads this category, winning 4 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
BGIN is the larger business by revenue, generating $302M annually — 2.6x HIVE's $115M. BGIN is the more profitable business, keeping 21.8% of every revenue dollar as net income compared to HIVE's -2.6%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $302M | $115M |
| EBITDAEarnings before interest/tax | — | $119M |
| Net IncomeAfter-tax profit | — | $21M |
| Free Cash FlowCash after capex | — | -$196M |
| Gross MarginGross profit ÷ Revenue | +42.2% | +21.8% |
| Operating MarginEBIT ÷ Revenue | +27.0% | +1.4% |
| Net MarginNet income ÷ Revenue | +21.8% | -2.6% |
| FCF MarginFCF ÷ Revenue | -70.2% | -136.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | -8.4% |
Valuation Metrics
Evenly matched — BGIN and HIVE each lead in 2 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, BGIN's 2.7x EV/EBITDA is more attractive than HIVE's 11.7x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $357M | $715M |
| Enterprise ValueMkt cap + debt − cash | $243M | $747M |
| Trailing P/EPrice ÷ TTM EPS | 6.79x | -122.65x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 2.66x | 11.73x |
| Price / SalesMarket cap ÷ Revenue | 1.18x | 6.20x |
| Price / BookPrice ÷ Book value/share | 2.14x | 0.82x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
BGIN leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
BGIN delivers a 36.7% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $3 for HIVE. BGIN carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIVE's 0.12x. On the Piotroski fundamental quality scale (0–9), BGIN scores 3/9 vs HIVE's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +36.7% | +3.3% |
| ROA (TTM)Return on assets | +28.5% | +3.0% |
| ROICReturn on invested capital | +61.8% | +0.3% |
| ROCEReturn on capital employed | +45.4% | +0.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 2 |
| Debt / EquityFinancial leverage | 0.00x | 0.12x |
| Net DebtTotal debt minus cash | -$114M | $32M |
| Cash & Equiv.Liquid assets | $115M | $23M |
| Total DebtShort + long-term debt | $445,403 | $55M |
| Interest CoverageEBIT ÷ Interest expense | — | -9.90x |
Total Returns (Dividends Reinvested)
HIVE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BGIN five years ago would be worth $7,944 today (with dividends reinvested), compared to $1,766 for HIVE. Over the past 12 months, HIVE leads with a +65.9% total return vs BGIN's -20.6%. The 3-year compound annual growth rate (CAGR) favors HIVE at -2.2% vs BGIN's -7.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +44.9% | +5.1% |
| 1-Year ReturnPast 12 months | -20.6% | +65.9% |
| 3-Year ReturnCumulative with dividends | -20.6% | -6.5% |
| 5-Year ReturnCumulative with dividends | -20.6% | -82.3% |
| 10-Year ReturnCumulative with dividends | -20.6% | +2770.0% |
| CAGR (3Y)Annualised 3-year return | -7.4% | -2.2% |
Risk & Volatility
BGIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BGIN is the less volatile stock with a 1.95 beta — it tends to amplify market swings less than HIVE's 3.16 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BGIN currently trades 60.6% from its 52-week high vs HIVE's 36.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.95x | 3.16x |
| 52-Week HighHighest price in past year | $6.50 | $7.84 |
| 52-Week LowLowest price in past year | $2.08 | $1.60 |
| % of 52W HighCurrent price vs 52-week peak | +60.6% | +36.6% |
| RSI (14)Momentum oscillator 0–100 | 61.3 | 68.7 |
| Avg Volume (50D)Average daily shares traded | 17K | 13.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $4.67 |
| # AnalystsCovering analysts | — | 9 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
BGIN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HIVE leads in 1 (Total Returns). 1 tied.
BGIN vs HIVE: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is BGIN or HIVE a better buy right now?
For growth investors, BGIN BLOCKCHAIN Ltd (BGIN) is the stronger pick with 17.
5% revenue growth year-over-year, versus 0. 7% for HIVE Digital Technologies Ltd. (HIVE). BGIN BLOCKCHAIN Ltd (BGIN) offers the better valuation at 6. 8x trailing P/E, making it the more compelling value choice. Analysts rate HIVE Digital Technologies Ltd. (HIVE) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BGIN or HIVE?
Over the past 5 years, BGIN BLOCKCHAIN Ltd (BGIN) delivered a total return of -20.
6%, compared to -82. 3% for HIVE Digital Technologies Ltd. (HIVE). Over 10 years, the gap is even starker: HIVE returned +27. 7% versus BGIN's -20. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BGIN or HIVE?
By beta (market sensitivity over 5 years), BGIN BLOCKCHAIN Ltd (BGIN) is the lower-risk stock at 1.
95β versus HIVE Digital Technologies Ltd. 's 3. 16β — meaning HIVE is approximately 62% more volatile than BGIN relative to the S&P 500. On balance sheet safety, BGIN BLOCKCHAIN Ltd (BGIN) carries a lower debt/equity ratio of 0% versus 12% for HIVE Digital Technologies Ltd. — giving it more financial flexibility in a downturn.
04Which is growing faster — BGIN or HIVE?
By revenue growth (latest reported year), BGIN BLOCKCHAIN Ltd (BGIN) is pulling ahead at 17.
5% versus 0. 7% for HIVE Digital Technologies Ltd. (HIVE). On earnings-per-share growth, the picture is similar: BGIN BLOCKCHAIN Ltd grew EPS -52. 5% year-over-year, compared to -108. 1% for HIVE Digital Technologies Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BGIN or HIVE?
BGIN BLOCKCHAIN Ltd (BGIN) is the more profitable company, earning 21.
8% net margin versus -2. 6% for HIVE Digital Technologies Ltd. — meaning it keeps 21. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BGIN leads at 27. 0% versus 1. 4% for HIVE. At the gross margin level — before operating expenses — BGIN leads at 42. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — BGIN or HIVE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is BGIN or HIVE better for a retirement portfolio?
For long-horizon retirement investors, BGIN BLOCKCHAIN Ltd (BGIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
HIVE Digital Technologies Ltd. (HIVE) carries a higher beta of 3. 16 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BGIN: -20. 6%, HIVE: +27. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between BGIN and HIVE?
These companies operate in different sectors (BGIN (Technology) and HIVE (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BGIN is a small-cap high-growth stock; HIVE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.